Latest / Inercia Cero: Corazón, Riñón y Metabolismo
Tirzepatida: State of the Art (2026)
Instagram: @dr.gilbertogarciabernal
Infografías en X: @DoctorGilbertoG
Tirzepatide in Adults With Type 1 Diabetes: A Phase 2 Randomized Placebo-Controlled Clinical Trial (Diabetes Care, 2026)
GLP-1RAs and tirzepatide may reduce heart failure risk in obese but not in non-obese patients with cardiovascular or renal disease: A systematic review and meta-analysis (Metabolism, 2026)
Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 Diabetes. SURPASS-CVOT (NEJM, 2025)
Real-world titration, persistence & weight loss of semaglutide and tirzepatide in an academic obesity…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.